In Treatment of Nausea Vombay Injection (2ml Each) blocks the action of chemicals in the body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused by cancer chemotherapy and radiation treatment (in adults and children aged 4 years and older). It is usually taken both before and after chemotherapy or radiation. This medicine helps you recover more comfortably from these treatments. It is also effective at preventing nausea and vomiting after an operation (in adults only). The dose will depend on what you are being treated for but always take this medicine as it is prescribed.
Consuming alcohol with Vombay Injection (2ml Each) does not cause any harmful side effects.
Vombay Injection (2ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Vombay Injection (2ml Each) is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Vombay Injection (2ml Each) does not usually affect your ability to drive.
Vombay Injection (2ml Each) is safe to use in patients with kidney disease. No dose adjustment of Vombay Injection (2ml Each) is recommended. However, inform your doctor if you have an underlying kidney disease. Limited information is available in patients taking this medicine for more than one day.
There is limited information available on the use of Vombay Injection (2ml Each) in patients with liver disease. Please consult your doctor.
If you miss a dose of Vombay Injection (2ml Each), take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Medlock Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Afive Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Santo Formulations || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Standard Remedies Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vibcare Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Themis Medicare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tulsi Medi Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Parex Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vaxova Drugs Pvt Ltd || ₹14.5/tablet (25% cheaper)